1. ShanahanF. The colonic microbiota in health and disease. Curr Opin Gastroenterol2013;29:49. CrossRef

2. Al‐HerzW, BousfihaA, CasanovaJL, et al.Primary immunodeficiency diseases: an update on the classification from the international union of immunological societies expert committee for primary immunodeficiency. Front Immunol.2014;5:1.

3. BoyleJM, BuckleyRH. Population prevalence of diagnosed primary immunodeficiency diseases in the United States. J Clin Immunol2007;27:497. CrossRef

4. YelL. Selective IgA deficiency. J Clin Immunol2010;30:10. CrossRef

5. de VriesE, European Society for Immunodeficiencies (ESID) members. Patient‐centred screening for primary immunodeficiency, a multi‐stage diagnostic protocol designed for non‐immunologists: 2011 update. Clin Exp Immunol2012;167:108. CrossRef

6. SeymourB, MilesJ, HaeneyM. Primary antibody deficiency and diagnostic delay. J Clin Pathol2005;58:546. CrossRef

7. AgarwalS, MayerL. Diagnosis and treatment of gastrointestinal disorders in patients with primary immunodeficiency. Clin Gastroenterol Hepatol2013;11:1050. CrossRef

8. WoodP, StanworthS, BurtonJ, et al.Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol2007;149:410. CrossRef

9. TsukadaS, SaffranDC, RawlingsDJ, et al.Deficient expression of a B cell cytoplasmic tyrosine kinase in human X‐linked agammaglobulinemia. Cell1993;72:279. CrossRef

10. HermaszewskiRA, WebsterAD. Primary hypogammaglobulinaemia: a survey of clinical manifestations and complications. Q J Med1993;86:31.

11. QuartierP, ForayS, CasanovaJL, et al.Enteroviral meningoencephalitis in X‐linked agammaglobulinemia: intensive immunoglobulin therapy and sequential viral detection in cerebrospinal fluid by polymerase chain reaction. Pediatr Infect Dis J2000;19:1106. CrossRef

12. MacLennanC, DunnG, HuissoonAP, et al.Failure to clear persistent vaccine‐derived neurovirulent poliovirus infection in an immunodeficient man. Lancet2004;363:1509. CrossRef

13. HammarströmL, VorechovskyI, WebsterD. Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID). Clin Exp Immunol2000;120:225. CrossRef

14. PiaścikM, RydzewskaG, PawlikM, et al.Diffuse nodular lymphoid hyperplasia of the gastrointestinal tract in patient with selective immunoglobulin. A deficiency and sarcoid‐like syndrome–case report. Adv Med Sci.2007;52:296.

15. QuigleyEM, CarmichaelHA, WatkinsonG. Adult celiac disease (celiac sprue), pernicious anemia and IgA deficiency. Case report and review of the relationships between vitamin B12 deficiency, small intestinal mucosal disease and immunoglobulin deficiency. J Clin Gastroenterol1986;8:277. CrossRef

16. AsadaY, IsomotoH, ShikuwaS, et al.Development of ulcerative colitis during the course of rheumatoid arthritis: association with selective IgA deficiency. World J Gastroenterol2006;12:5240.

17. SandlerSG. How I manage patients suspected of having had an IgA anaphylactic transfusion reaction. Transfusion2006;46:10. CrossRef

18. DaviesEG, ThrasherAJ. Update on the hyper immunoglobulin M syndromes. Br J Haematol2010;149:167. CrossRef

19. LevyJ, Espanol‐BorenT, ThomasC, et al.Clinical spectrum of X‐linked hyper‐IgM syndrome. J Pediatr1997;131:47. CrossRef

20. HaywardAR, LevyJ, FacchettiF, et al.Cholangiopathy and tumors of the pancreas, liver, and biliary tree in boys with X‐linked immunodeficiency with hyper‐IgM. J Immunol1997;158:977.

21. HadzićN, PagliucaA, RelaM, et al.Correction of the hyper‐IgM syndrome after liver and bone marrow transplantation. N Engl J Med2000;342:320. CrossRef

22. ResnickES, Cunningham‐RundlesC. The many faces of the clinical picture of common variable immune deficiency. Curr Opin Allergy Clin Immunol2012;12:595. CrossRef

23. ResnickES, MoshierE, GodboldJ, et al.Morbidity and mortality in common variable immunodeficiency over 4 decades. Blood2012;119:1650. CrossRef

24. WehrC, KiviojaT, SchmittC, et al.The EUROclass trial: defining subgroups in common variable immunodeficiency. Blood2008;111:77. CrossRef

25. OrangeJS, GlessnerJT, ResnickE, et al.Genome‐wide association identifies diverse causes of common variable immunodeficiency. J Allergy Clin Immunol2011;127:1360. CrossRef

26. MalamutG, VerkarreV, SuarezF, et al.The enteropathy associated with common variable immunodeficiency: the delineated frontiers with celiac disease. Am J Gastroenterol2010;105:2262. CrossRef

27. ChuaI, StandishR, LearS, et al.Anti‐tumour necrosis factor‐alpha therapy for severe enteropathy in patients with common variable immunodeficiency (CVID). Clin Exp Immunol2007;150:306. CrossRef

28. Cunningham‐RundlesC, BodianC. Common variable immunodeficiency: clinical and immunological features of 248 patients. Clin Immunol1999;92:34. CrossRef

29. MalamutG, ZiolM, SuarezF, et al.Nodular regenerative hyperplasia: the main liver disease in patients with primary hypogammaglobulinemia and hepatic abnormalities. J Hepatol2008;48:74. CrossRef

30. International Union of Immunological Societies Expert Committee on Primary Immunodeficiencies, NotarangeloLD, FischerA, et al.Primary immunodeficiencies: 2009 update. J Allergy Clin Immunol2009;124:1161. Erratum in: J Allergy Clin Immunol 2010;125(3):771–3. CrossRef

31. VerbskyJ, ThakarM, RoutesJ. The Wisconsin approach to newborn screening for severe combined immunodeficiency. J Allergy Clin Immunol2012;129:622. CrossRef

32. WorthAJ, BoothC, VeysP. Stem cell transplantation for primary immune deficiency. Curr Opin Hematol2013;20:501. CrossRef

33. FischerA, Hacein‐Bey‐AbinaS, Cavazzana‐CalvoM. Gene therapy of primary T cell immunodeficiencies. Gene2013;525:170. CrossRef

34. OrangeJS, JainA, BallasZK, et al.The presentation and natural history of immunodeficiency caused by nuclear factor kappaB essential modulator mutation. J Allergy Clin Immunol2004;113:725. CrossRef

35. OchsHD, FilipovichAH, VeysP, et al.Wiskott‐Aldrich syndrome: diagnosis, clinical and laboratory manifestations, and treatment. Biol Blood Marrow Transplant2009;15(1 Suppl):84. CrossRef

36. Dupuis‐GirodS, MedioniJ, HaddadE, et al.Autoimmunity in Wiskott‐Aldrich syndrome: risk factors, clinical features, and outcome in a single‐center cohort of 55 patients. Pediatrics2003;111:e622. CrossRef

37. HollandSM. Chronic granulomatous disease. Hematol Oncol Clin North Am2013;27:89. CrossRef

38. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group. N Engl J Med1991;324:509. CrossRef

39. HussainN, FeldJJ, KleinerDE, et al.Hepatic abnormalities in patients with chronic granulomatous disease. Hepatology2007;45:675. CrossRef

40. LeidingJW, FreemanAF, MarcianoBE, et al.Corticosteroid therapy for liver abscess in chronic granulomatous disease. Clin Infect Dis2012;54:694. CrossRef

41. AlimchandaniM, LaiJP, AungPP, et al.Gastrointestinal histopathology in chronic granulomatous disease: a study of 87 patients. Am J Surg Pathol2013;37:1365. CrossRef

42. UzelG, OrangeJS, PoliakN, et al.Complications of tumor necrosis factor‐α blockade in chronic granulomatous disease‐related colitis. Clin Infect Dis2010;51:1429. CrossRef

43. TorgersonTR, OchsHD. Immune dysregulation, polyendocrinopathy, enteropathy, X‐linked: forkhead box protein 3 mutations and lack of regulatory T cells. J Allergy Clin Immunol2007;120:744. CrossRef

44. KühnR, LöhlerJ, RennickD, et al.Interleukin‐10‐deficient mice develop chronic enterocolitis. Cell1993;75:263. CrossRef

45. GlockerEO, KotlarzD, KleinC, et al.IL‐10 and IL‐10 receptor defects in humans. Ann N Y Acad Sci2011;1246:102. CrossRef

46. Miceli‐RichardC, LesageS, RybojadM, et al.CARD15 mutations in Blau syndrome. Nat Genet2001;29:19. CrossRef

47. KastnerDL, AksentijevichI, Goldbach‐ManskyR. Autoinflammatory disease reloaded: a clinical perspective. Cell2010;140:784. CrossRef

48. French FMF Consortium. A candidate gene for familial Mediterranean fever. Nat Genet1997;17:25. CrossRef

49. Ancient missense mutations in a new member of the RoRet gene family are likely to cause familial Mediterranean fever. The International FMF Consortium. Cell1997;90:797. CrossRef

50. McDermottMF, AksentijevichI, GalonJ, et al.Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes. Cell1999;97:133. CrossRef

51. SkattumL, van DeurenM, van der PollT, et al.Complement deficiency states and associated infections. Mol Immunol2011;48:1643. CrossRef

52. LonghurstH, CicardiM. Hereditary angio‐oedema. Lancet2012;379:474. CrossRef

53. KaplanAP, JosephK. The bradykinin‐forming cascade and its role in hereditary angioedema. Ann Allergy Asthma Immunol2010;104:193. CrossRef

54. BorkK, StaubachP, EckardtAJ, et al.Symptoms, course, and complications of abdominal attacks in hereditary angioedema due to C1 inhibitor deficiency. Am J Gastroenterol2006;101:619. CrossRef

55. TarziMD, HickeyA, FörsterT, et al.An evaluation of tests used for the diagnosis and monitoring of C1 inhibitor deficiency: normal serum C4 does not exclude hereditary angio‐oedema. Clin Exp Immunol2007;149:513. CrossRef

56. ZurawBL, BussePJ, WhiteM, et al.Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med2010;363:513. CrossRef

57. CicardiM, BanerjiA, BrachoF, et al.Icatibant, a new bradykinin‐receptor antagonist, in hereditary angioedema. N Engl J Med2010;363:532. CrossRef

58. CicardiM, LevyRJ, McNeilDL, et al.Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med2010;363:523. CrossRef

59. CicardiM, BorkK, CaballeroT, et al.Evidence‐based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy2012;67:147. CrossRef

60. UhligHH. Monogenic diseases associated with intestinal inflammation: implications for the understanding of inflammatory bowel disease. Gut2013;62:1795. CrossRef

61. MarksDJ, MiyagiK, RahmanFZ, et al.Inflammatory bowel disease in CGD reproduces the clinicopathological features of Crohn's disease. Am J Gastroenterol2009;104:117. CrossRef

62. FerraraJL, LevineJE, ReddyP, et al.Graft‐versus‐host disease. Lancet2009;373:1550. CrossRef

63. VogelsangGB, LeeL, Bensen‐KennedyDM. Pathogenesis and treatment of graft‐versus‐host disease after bone marrow transplant. Annu Rev Med2003;54:29. CrossRef

64. SchulenburgA, TuretschekK, WrbaF, et al.Early and late gastrointestinal complications after myeloablative and nonmyeloablative allogeneic stem cell transplantation. Ann Hematol2004;83:101. CrossRef

65. PottenCS. Epithelial cell growth and differentiation. II. Intestinal apoptosis. Am J Physiol1997;273:G253.

66. WashingtonK, JagasiaM. Pathology of graft‐versus‐host disease in the gastrointestinal tract. Hum Pathol2009;40:909. CrossRef

67. DavilaML. Neutropenic enterocolitis. Curr Treat Options Gastroenterol2006;9:249. CrossRef

68. ShidhamVB, ChangCC, ShidhamG, et al.Colon biopsies for evaluation of acute graft‐versus‐host disease (A‐GVHD) in allogeneic bone marrow transplant patients. BMC Gastroenterol2003;3:5. CrossRef

69. AkiraS, UematsuS, TakeuchiO. Pathogen recognition and innate immunity. Cell2006;124:783. CrossRef

70. FerraraJL, ReddyP. Pathophysiology of graft‐versus‐host disease. Semin Hematol2006;43:3. CrossRef

71. HillGR, FerraraJL. The primacy of the gastrointestinal tract as a target organ of acute graft‐versus‐host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation. Blood2000;95:2754.

72. MurphyS, NguyenVH. Role of gut microbiota in graft‐versus‐host disease. Leuk Lymphoma2011;52:1844. CrossRef

73. FilipovichAH, WeisdorfD, PavleticS, et al.National Institutes of Health consensus development project on criteria for clinical trials in chronic graft‐versus‐host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant2005;11:945. CrossRef

74. MartinPJ, McDonaldGB, SandersJE, et al.Increasingly frequent diagnosis of acute gastrointestinal graft‐versus‐host disease after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant2004;10:320. CrossRef

75. HarrisAC, FerraraJL, BraunTM, et al.Plasma biomarkers of lower gastrointestinal and liver acute GVHD. Blood2012;119:2960. CrossRef

76. MahgereftehSY, SosnaJ, BogotN, et al.Radiologic imaging and intervention for gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. Radiology2011;258:660. CrossRef

77. GarnettC, ApperleyJF, PavlůJ. Treatment and management of graft‐versus‐host disease: improving response and survival. Ther Adv Hematol.2013;4:366. CrossRef

78. HockenberyDM, CruickshankS, RodellTC, et al.A randomized, placebo‐controlled trial of oral beclomethasone dipropionate as a prednisone‐sparing therapy for gastrointestinal graft‐versus‐host disease. Blood2007;109:4557. CrossRef

79. WagnerJE, ThompsonJS, CarterSL, et al.Effect of graft‐versus‐host disease prophylaxis on 3‐year disease‐free survival in recipients of unrelated donor bone marrow (T‐cell Depletion Trial): a multi‐centre, randomised phase II‐III trial. Lancet2005;366:733. CrossRef

80. BolwellB, SobecksR, PohlmanB, et al.A prospective randomized trial comparing cyclosporine and short course methotrexate with cyclosporine and mycophenolate mofetil for GVHD prophylaxis in myeloablative allogeneic bone marrow transplantation. Bone Marrow Transplant2004;34:621. CrossRef

81. MielcarekM, MartinPJ, LeisenringW, et al.Graft‐versus‐host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood2003;102:756. CrossRef

82. McDonaldGB, SullivanKM, SchufflerMD, et al.Esophageal abnormalities in chronic graft‐versus‐host disease in humans. Gastroenterology1981;80:914.

83. AkpekG, ChinratanalabW, LeeLA, et al.Gastrointestinal involvement in chronic graft‐versus‐host disease: a clinicopathologic study. Biol Blood Marrow Transplant2003;9:46. CrossRef

84. NishidaT, HamaguchiM, HirabayashiN, et al.Intestinal thrombotic microangiopathy after allogeneic bone marrow transplantation: a clinical imitator of acute enteric graft‐versus‐host disease. Bone Marrow Transplant2004;33:1143. CrossRef

85. TuncerHH, RanaN, MilaniC, et al.Gastrointestinal and hepatic complications of hematopoietic stem cell transplantation. World J Gastroenterol2012;18:1851. CrossRef

86. FujiiN, TakenakaK, ShinagawaK, et al.Hepatic graft‐versus‐host disease presenting as an acute hepatitis after allogeneic peripheral blood stem cell transplantation. Bone Marrow Transplant2001;27:1007. CrossRef